We gratefully acknowledge support from
the Simons Foundation and member institutions.
Full-text links:

Download:

Current browse context:

stat.AP

Change to browse by:

References & Citations

Bookmark

(what is this?)
CiteULike logo BibSonomy logo Mendeley logo del.icio.us logo Digg logo Reddit logo ScienceWISE logo

Statistics > Applications

Title: Assessing the Most Vulnerable Subgroup to Type II Diabetes Associated with Statin Usage: Evidence from Electronic Health Record Data

Abstract: There have been increased concerns that the use of statins, one of the most commonly prescribed drugs for treating coronary artery disease, is potentially associated with the increased risk of new-onset type II diabetes (T2D). Nevertheless, to date, there is no robust evidence supporting as to whether and what kind of populations are indeed vulnerable for developing T2D after taking statins. In this case study, leveraging the biobank and electronic health record data in the Partner Health System, we introduce a new data analysis pipeline and a novel statistical methodology that address existing limitations by (i) designing a rigorous causal framework that systematically examines the causal effects of statin usage on T2D risk in observational data, (ii) uncovering which patient subgroup is most vulnerable for developing T2D after taking statins, and (iii) assessing the replicability and statistical significance of the most vulnerable subgroup via a bootstrap calibration procedure. Our proposed approach delivers asymptotically sharp confidence intervals and debiased estimate for the treatment effect of the most vulnerable subgroup in the presence of high-dimensional covariates. With our proposed approach, we find that females with high T2D genetic risk are at the highest risk of developing T2D due to statin usage.
Comments: 25 pages, 2 figures, 5 tables
Subjects: Applications (stat.AP); Methodology (stat.ME)
Cite as: arXiv:2205.06960 [stat.AP]
  (or arXiv:2205.06960v3 [stat.AP] for this version)

Submission history

From: Waverly Wei [view email]
[v1] Sat, 14 May 2022 03:50:24 GMT (3538kb,D)
[v2] Sat, 24 Sep 2022 23:35:59 GMT (4825kb,D)
[v3] Sat, 22 Oct 2022 01:11:36 GMT (4825kb,D)

Link back to: arXiv, form interface, contact.